←Back to Expert Scholars
Translational Medicine / 转化医学RCC Belzutifan/HIF-2
Sumanta Pal
MD
🏢City of Hope🌐USA
Co-Director, Kidney Cancer Program
62
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Sumanta Pal is a prominent kidney cancer specialist advancing treatment optimization and novel combination strategies including belzutifan-based regimens. His research on treatment sequencing and non-clear cell RCC has addressed critical knowledge gaps. He leads innovative clinical trials and patient advocacy efforts in kidney cancer.
Share:
🧪Research Fields 研究领域
Renal cell carcinoma
Targeted therapy sequencing
Belzutifan combinations
Non-clear cell RCC
Clinical informatics
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Sumanta Pal 的研究动态
Follow Sumanta Pal's research updates
留下邮箱，当我们发布与 Sumanta Pal（City of Hope）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment